We are live on ! Find out more
LLY icon

Eli Lilly
LLY

4,598 hedge funds and large institutions have $941B invested in Eli Lilly in 2026 Q2 according to their latest regulatory filings, with 411 funds opening new positions, 2,196 increasing their positions, 1,468 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

284% more first-time investments, than exits

New positions opened: 411 | Existing positions closed: 107

50% more repeat investments, than reductions

Existing positions increased: 2,196 | Existing positions reduced: 1,468

32% more capital invested

Capital invested by funds: $714B → $941B (+$227B)

24% more funds holding in top 10

Funds holding in top 10: 378 → 467 (+89)

23% more call options, than puts

Call options by funds: $23.7B | Put options by funds: $19.2B

5% more funds holding

Funds holding: 4,373 → 4,598 (+225)

1.27% more ownership

Funds ownership: 82.16% → 83.43% (+1.3%)

Holders
4,598
Holders Change
+225
Holders Change %
+5.15%
% of All Funds
55.57%
Holding in Top 10
467
Holding in Top 10 Change
+89
Holding in Top 10 Change %
+23.54%
% of All Funds
5.64%
New
411
Increased
2,196
Reduced
1,468
Closed
107
Calls
$23.7B
Puts
$19.2B
Net Calls
+$4.47B
Net Calls Change
+$8.39B

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.17B
2
SG Americas Securities
SG Americas Securities
New York
+$1.36B
3
Goldman Sachs
Goldman Sachs
New York
+$1.34B
4
BlackRock
BlackRock
New York
+$1.18B
5
Morgan Stanley
Morgan Stanley
New York
+$806M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$3.84B
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.48B
3
Lilly Endowment
Lilly Endowment
Indiana
-$1.55B
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.12B
5
DAM
Diamant Asset Management
Connecticut
-$1.09B
Name Holding Trade Value Shares
Change 		Change in
Stake
Fisher Asset Management
26
Fisher Asset Management
Washington
$6.07B +$229M +224,530 +5%
Nuveen
27
Nuveen
North Carolina
$6.07B -$282M -276,162 -5%
Amundi
28
Amundi
France
$5.77B -$252M -246,882 -5%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$5.74B -$78.6M -76,949 -2%
Wells Fargo
30
Wells Fargo
California
$5.57B +$245M +240,275 +5%
Vanguard Fiduciary Trust
31
Vanguard Fiduciary Trust
Pennsylvania
$5.51B -$27.8M -27,178 -0.6%
Franklin Resources
32
Franklin Resources
California
$5.51B +$121M +118,440 +3%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$5.23B +$98M +95,870 +2%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$4.8B +$110M +107,492 +3%
JT
35
Jupiter Topco
New York
$4.67B +$3.98B +3,891,118 New
UBS Group
36
UBS Group
Switzerland
$4.64B -$181M -177,637 -4%
Invesco
37
Invesco
Georgia
$4.43B +$245M +239,567 +7%
Deutsche Bank
38
Deutsche Bank
Germany
$4.05B -$172M -168,145 -5%
AllianceBernstein
39
AllianceBernstein
Tennessee
$3.92B -$170M -166,379 -4%
Ameriprise
40
Ameriprise
Minnesota
$3.6B +$12.5M +12,277 +0.4%
American Century Companies
41
American Century Companies
Missouri
$2.82B +$520M +508,915 +28%
Swiss National Bank
42
Swiss National Bank
Switzerland
$2.72B -$95.2M -93,160 -4%
Victory Capital Management
43
Victory Capital Management
Texas
$2.57B +$281M +274,593 +15%
Mitsubishi UFJ Asset Management
44
Mitsubishi UFJ Asset Management
Japan
$2.42B +$135M +131,669 +7%
HSBC Holdings
45
HSBC Holdings
United Kingdom
$2.39B +$126M +122,907 +7%
SG Americas Securities
46
SG Americas Securities
New York
$2.38B +$1.36B +1,331,427 +204%
Sumitomo Mitsui Trust Group
47
Sumitomo Mitsui Trust Group
Japan
$2.27B +$123M +120,058 +7%
Swedbank
48
Swedbank
Sweden
$2.14B +$169M +165,006 +10%
Fifth Third Bancorp
49
Fifth Third Bancorp
Ohio
$2.1B -$217M -212,702 -11%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$2.07B +$222M +217,333 +14%
1
2
3 4 5

LLY Hedge Fund Activity: Q2 2026 in Review

4,598 of the 8,274 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2026, worth a combined $941B — up 32% from $714B a quarter earlier.

Buyers outnumbered sellers: 411 funds opened new LLY positions and 107 closed out — a net gain of 304 holders — while 2,196 added to existing stakes and 1,468 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $2.17B. The largest seller was Capital Research Global Investors, cutting an estimated $3.84B.

  • 4,598 institutional investors held Eli Lilly (LLY) as of Q2 2026, up from 4,373 in Q1 2026.
  • Funds reported $941B of Eli Lilly stock for Q2 2026, up 32% quarter-over-quarter.
  • 411 funds opened new Eli Lilly positions in Q2 2026 and 107 closed out, a net change of +304 holders.
  • The largest Eli Lilly buyer in Q2 2026 was Fidelity Investments, an estimated $2.17B added.
  • The largest Eli Lilly seller in Q2 2026 was Capital Research Global Investors, an estimated $3.84B sold.

Based on aggregated 13F filings for Q2 2026.